The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(4-(1H-imidazol-1-yl)phenoxy)-1-(benzo[d][1,3]dioxol-5-ylmethyl)azepane ID: ALA388880
PubChem CID: 10475555
Max Phase: Preclinical
Molecular Formula: C23H25N3O3
Molecular Weight: 391.47
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: c1cn(-c2ccc(OC3CCCCN(Cc4ccc5c(c4)OCO5)C3)cc2)cn1
Standard InChI: InChI=1S/C23H25N3O3/c1-2-11-25(14-18-4-9-22-23(13-18)28-17-27-22)15-21(3-1)29-20-7-5-19(6-8-20)26-12-10-24-16-26/h4-10,12-13,16,21H,1-3,11,14-15,17H2
Standard InChI Key: HGPUMTWTRGEZDO-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 33 0 0 0 0 0 0 0 0999 V2000
12.1400 -11.0010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5593 -10.2881 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1472 -9.5670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3231 -9.5640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3145 -10.9944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9050 -10.2790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0981 -10.4473 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.0088 -11.2669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7606 -11.6049 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.5626 -8.8542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1530 -8.1381 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0108 -6.6818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7554 -6.3354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4968 -6.7016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8181 -7.4859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6751 -7.5057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3269 -8.1370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1459 -6.1924 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.9114 -6.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0263 -7.3181 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7910 -7.6257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4411 -7.1163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3214 -6.2957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5567 -5.9919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2070 -7.4229 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.4106 -8.2191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2338 -8.2740 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.5403 -7.5080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9066 -6.9799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12 15 1 0
3 4 2 0
14 16 1 0
6 7 1 0
15 17 1 0
16 11 1 0
17 11 1 0
7 8 1 0
14 18 1 0
8 9 1 0
18 19 1 0
9 5 1 0
19 20 2 0
4 6 1 0
20 21 1 0
3 10 1 0
21 22 2 0
5 6 2 0
22 23 1 0
10 11 1 0
23 24 2 0
24 19 1 0
1 2 2 0
22 25 1 0
25 26 1 0
5 1 1 0
12 13 1 0
2 3 1 0
13 14 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 391.47Molecular Weight (Monoisotopic): 391.1896AlogP: 4.03#Rotatable Bonds: 5Polar Surface Area: 48.75Molecular Species: BASEHBA: 6HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 8.52CX LogP: 3.86CX LogD: 2.69Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.66Np Likeness Score: -1.30
References 1. Wei RG, Adler M, Davey D, Ho E, Mohan R, Polokoff M, Tseng JL, Whitlow M, Xu W, Yuan S, Phillips G.. (2007) 1-(1,3-Benzodioxol-5-ylmethyl)-3-[4-(1H-imidazol-1-yl)phenoxy]-piperidine analogs as potent and selective inhibitors of nitric oxide formation., 17 (9): [PMID:17368901 ] [10.1016/j.bmcl.2007.02.053 ]